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Primary liver cancer, including hepatocellular carcinoma (HCC), is the sixth most common cancer in the world 
(1), with a mean 5-year survival rate of 5%–20% (2). 
Curative treatment for HCC can be achieved with sur-
gical resection, liver transplantation, or radiofrequency 
ablation. According to the Barcelona Clinic Liver Cancer 
criteria, curative treatment is only advocated to asymp-
tomatic patients with early HCC (3). Thus, as early di-
agnosis is crucial to enable curative treatment, improving 
the HCC detection rate would be directly beneficial for 
patient care and survival.
Currently, the diagnosis of HCC is predominantly based 
on cross-sectional imaging (4,5), and needle biopsy is only 
seldomly required. Imaging-based diagnosis of HCC relies 
on HCC-specific imaging features in patients with chronic 
liver disease, including hyperenhancement on late arterial 
phase images and washout at the portal venous and/or de-
layed phases of multiphasic contrast material–enhanced 
imaging. However, previous studies have shown that arte-
rial hyperenhancement can be absent in as many as 18% 
of HCCs (6). Accordingly, the detection rate of HCC, es-
pecially when smaller than 2 cm, is poor at multiphasic 
CT and MRI (7–9), which might be due either to a 
weak arterial supply of early HCC or to suboptimal 
arterial phase timing of standard multiphasic imaging 
(10). Multiple arterial phase imaging with MRI (11), 
as well as arterial perfusion maps derived from several 
arterial time points of a CT perfusion study, have been 
shown to improve the sensitivity for detecting HCC 
(12), underlining the importance of accurate contrast 
material timing in HCC.
Acquisition of multiple arterial subphases by using CT 
is associated with a substantial increase in radiation dose 
compared with single-phase imaging. However, recent 
developments in postprocessing of perfusion CT with a 
spatiotemporal multiband (frequency dependent) filtering 
technique allow substantial noise reduction and fusion of 
images from several arterial time points into a single time-
resolved maximum intensity projection (MIP) (13,14). 
These postprocessing steps were shown to improve image 
quality (15). Consequently, as each arterial time point can 
be acquired at very low doses, fusion of images from several 
arterial time points into a single time-resolved MIP might 
increase the detection rate of HCC compared with that at 
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Purpose: To develop and evaluate a triple arterial phase CT liver protocol with a similar radiation dose to that of standard single 
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single arterial phase CT (P , .001 and P = .032, respectively); however, there was no significant difference in lesion-to-liver-
contrast ratio (P = .31). Subjective image quality was good for both protocols. The detection rate of the 65 HCC lesions was 82% 
for reader 1 and 83% for reader 2 at triple arterial phase CT and 80% for reader 1 and 77% for reader 2 at standard single arterial 
phase CT (P = .4).
Conclusion: Triple arterial phase imaging is feasible at the same radiation dose as that used for standard single arterial phase CT. 
Triple arterial phase imaging provides equivalent to superior image quality and equal HCC detection rate despite the use of less 
than half the contrast material dose used at standard single arterial phase CT.
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Abbreviations
HCC = hepatocellular carcinoma, JAFROC = jackknife alternative free-
response receiver operating characteristic, MIP = maximum intensity 
projection, ROI = region of interest
Summary
The triple arterial phase maximum intensity projection (MIP) protocol 
is feasible at the same radiation dose as that used with a standard single 
arterial phase protocol by using a new postprocessing technique. Triple 
arterial phase MIP provides equivalent-to-superior image quality and 
an equal hepatocellular carcinoma detection rate despite using less than 
half the contrast material dose used at standard single arterial phase CT.
Implications for Patient Care
 n Fusion of low-radiation-dose images obtained at three time points 
improves the contrast-to-noise ratio at arterial phase imaging with-
out increasing total radiation dose.
 n The possibility of reducing contrast material dose from 120 mL to 
50 mL without compromising hypervascular lesion detection sen-
sitivity at liver imaging might be useful for patients with chronic 
kidney disease.
 n The detection of hepatocellular carcinoma might improve if triple 
arterial phase imaging is integrated in a standard full contrast ma-
terial dose CT protocol.
standard late arterial phase CT by combining information from 
several arterial phases and/or time points.
Our aim was to design a multiple arterial phase protocol 
with a dose equivalent to that with a standard late arterial 
phase protocol by means of image fusion and noise reduc-
tion of several arterial time points. Moreover, we evaluated 
the detection rate of HCC by comparing the newly designed 
multiarterial phase protocol with the standard late arterial 
phase protocol.
Materials and Methods
The regional ethical review board approved the study, and 
informed consent was obtained. The study consisted of two 
parts. In the first part, a dose-equivalent triple arterial phase 
MIP protocol was retrospectively designed from previously ac-
quired perfusion CT data. In the second part, triple arterial 
phase time-resolved MIP images were prospectively simulated 
and compared with late arterial phase (single arterial phase) 
images from standard CT for evaluation.
Design of a Dose-equivalent Triple Arterial Phase 
Protocol
Group A.—The retrospective study group (group A) con-
sisted of 15 subjects who underwent perfusion CT between 
March 2012 and August 2014. There were 13 men (87%) 
and two women (13%), with a mean age (6standard devia-
tion) of 65 years 6 10 (range, 53–84 years). The subjects 
had liver cirrhosis due to either viral hepatitis (nine subjects, 
60%) or alcoholic liver disease (six subjects, 40%). There was 
a total of 27 HCC lesions in the 15 subjects. Nine of the 15 
subjects (60%) had Child-Pugh class A disease, five subjects 
(33%) had Child-Pugh class B disease, and one subject (7%) 
had Child-Pugh class C disease.
Arterial peak enhancement of HCC.—The average volume 
CT dose index (in milligrays) at a single time point of a low-
dose dynamic perfusion protocol was compared with volume 
CT dose index values at the late arterial phase of a standard 
liver CT protocol with the same kilovolt setting (80 kV). The 
evaluation showed that the combined radiation dose of three 
time points of perfusion CT was equivalent to that at one 
standard arterial phase at the reported protocol parameters 
(Tables 1, 2).
Thereafter, we obtained time-attenuation curves of all 27 
HCCs in group A. Peak enhancement times were determined 
by using commercially available postprocessing software (CT 
Dynamic Angio, syngo.via; Siemens Healthineers, Forchheim, 
Germany). The peak enhancement times were corrected for 
cardiac output variations by subtracting the time until 160 
Hounsfield units (HU) was reached in the abdominal aorta, 
simulating the bolus-tracking technique for contrast mate-
rial timing. Minimum, mean, and maximum values of these 
corrected peak enhancement times served as the reference for 
prospectively selecting three arterial time points for the triple 
arterial phase protocol (Fig 1).
Performance of the Dose-equivalent Triple Arterial 
Phase Protocol
Group B.—Between August 2013 and September 2014, 44 
consecutive study participants (group B) known to have or with 
a high probability of having HCC underwent dynamic perfu-
sion CT and clinically indicated standard multiphasic liver CT 
on the same day by using a second-generation dual-source CT 
scanner (Somatom Definition Flash, Siemens Healthineers). 
Exclusion criteria were as follows: age younger than 50 years, 
renal insufficiency (defined as serum creatinine level ,1.2 mg/
dL), or known iodine intolerance. Four of the 44 subjects (9%) 
were excluded for technical reasons, including incorrect kilo-
volt settings (n = 2), insufficient liver coverage (n = 1), and 
delayed scanning start (n = 1). Two other participants (5%) 
had to be excluded because they had more than 10 liver lesions. 
Thus, a total of 38 subjects were included.
Of the 38 participants in group B, there were 33 men (87%) 
and five women (13%). The mean age was 66 years 6 8 (range, 
51–87 years). Thirty-two of the 38 participants (84%) had cir-
rhosis and two (5%) had fibrosis. Four of the 38 participants 
(11%) had neither cirrhosis nor fibrosis. Of the 32 participants 
with cirrhosis, 21 subjects (66%) had Child-Pugh class A dis-
ease, 10 subjects (31%) had Child-Pugh class B disease, and one 
subject (3%) had Child-Pugh class C disease. The main reasons 
for cirrhosis were hepatitis C virus infection (n = 12), hepatitis 
C virus infection combined with alcoholic liver disease (n = 8), 
alcoholic liver disease (n = 3), and nonalcoholic fatty liver disease 
(n = 2). For one study participant, the cause of cirrhosis was 
unknown. In the remaining six subjects, cirrhosis was caused by 
cryptogenic cirrhosis (n = 1), primary sclerosing cholangitis (n = 
1), autoimmune hepatitis (n = 1), hepatitis B virus infection (n 
= 1), hepatitis B virus infection combined with hepatitis C virus 
infection (n = 1), and hepatitis C virus infection combined with 
hemochromatosis (n = 1).
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Of the 53 participants from group A 
and B combined, 15 subjects have been 
previously reported on in other published 
studies (12,15–17). However, the current 
study exploits a different study aim, meth-
odology, and results as compared with the 
previous publications. Whereas previous 
studies dealt with perfusion CT of the 
liver and focused on technical refinements 
of the perfusion CT technique (15,17), as 
well as on diagnostic performance of per-
fusion mapping for the detection of HCC 
(12,16), the present study evaluates the 
feasibility, image quality, and diagnostic ac-
curacy of a newly developed triple arterial 
phase CT liver protocol.
CT imaging and reconstruction.—The 
scanning and contrast material proto-
cols for standard CT and perfusion CT 
are detailed in Table 1. Although both 
examinations were performed at 80 kV, 
a significantly lower amount of contrast 
material was used for the perfusion CT 
protocol (mean volume, 50 mL) than for 
the standard CT protocol (mean volume, 
120 mL) (P < .001).
Triple arterial phase MIP reconstruc-
tion was performed for all 38 study sub-
jects in group B by using the same soft-
ware application as mentioned earlier. A 
triple-phase MIP is a time-resolved MIP 
that displays information from all three 
arterial time points in one image set. 
The images from the three prospectively 
defined time points were identified and 
fused after motion correction and noise-
reduction postprocessing steps were ap-
plied. For noise reduction, a multiband 
spatiotemporal filter was used. This postprocessing technique 
first separates high- and low-frequency bands. For the low 
frequencies, which contain contrast material information and 
time-attenuation information, the original data are preserved. 
Edges and noise, on the other hand, are covered by high-
frequency bands. The high frequencies are averaged to reduce 
pixel noise. Last, high- and low-frequency bands are recom-
bined to create the final noise-reduced images (13,14).
Both the triple arterial phase MIP images derived from 
perfusion CT and the single arterial phase images de-
rived from standard CT were presented in axial stacks 
with 3-mm-thick sections and an increment of 1.5 mm.
HCC detection and subjective image quality assessment.—
Thirty-eight triple arterial phase MIP image sets and the cor-
responding 38 single arterial phase image sets were evaluated by 
two abdominal radiologists (reader 1 [A.T.] and reader 2 [N.V.], 
with 10 and 8 years of experience, respectively, in abdominal 
Table 1: CT Protocols
Parameter Perfusion CT
Standard Late Arterial  
Phase CT
Scanning parameter
 z-axis coverage (cm)* 19.2 (15.5–22.1) 26.0 (20.1–50.9)
 Scanning delay (sec) 8 Bolus tracking +20
 No. of scans* 28 (26–30) 1
 Scanning direction Craniocaudal alternating Craniocaudal
 Cycle time (sec) 1.5–1.75 …
 Total acquisition time (sec)* 48 (43–54) …
 Pitch … 0.7
 Tube voltage (kV) 80 80
 Tube current (mAs) 160 Automatic tube current 
 modulation
 Section collimation (mm) 128 3 0.6 128 3 0.6
 Gantry rotation time (msec) 285 500
Contrast material injection protocol
 Volume (mL) 50 120 (70–143), adjusted 
 to body weight
 Iodine concentration (mg/mL) 400 400
 Flow rate (mL/sec) 6 4.7 (2.9–5.6)
 Injection duration (sec) 8.3 25
* Data are means, with range in parentheses.
Table 2: Mean Radiation Doses
Parameter
Perfusion CT
Standard Late  
Arterial Phase CTSingle Time Point
Three Time Points  
(Triple Arterial Phase)
CTDIvol (mGy) 3.88 11.64 11.85
DLP (mGy 3 cm)* 74.50 223.32 227.52
Effective dose (mSv)† 1.12 3.35 3.41
Note.—CTDIvol = volume CT dose index, DLP = dose-length product.
* z-axis coverage was 19.2 cm.
† Abdominal conversion coefficient = 0.015.
CT). The readers independently read a mix of 19 randomly 
ordered triple arterial phase MIP image sets and a different set 
of 19 single arterial phase image sets on two separate occasions. 
The second reading took place 4 weeks after the first reading to 
minimize recall bias. Readers were blinded to all clinical infor-
mation and to the radiology report. Only minimal annotations 
were allowed in the picture archiving and communication sys-
tem (version IDS7; Sectra, Linköping, Sweden). Readers did not 
have access to the other series of the standard multiphasic liver 
CT (unenhanced scan, portal venous phase and delayed phase 
scans). The two readers assessed one image set at a time (ie, from 
either triple arterial phase MIP or single arterial phase MIP) to 
detect hypervascular lesions larger than 9 mm in diameter with a 
masslike and/or round appearance.
The number of HCC lesions was defined by a reference reader 
(reader 3 [K.B.], with 7 years of experience in abdominal CT) 
with use of the complete multiphasic standard CT set (unen-
hanced scan and late arterial, portal venous, and delayed phase 
Triple Arterial Phase CT of the Liver
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ings were determined. Confidence ratings (of the Likert Scale) 
were analyzed by using the jackknife alternative free-response 
receiver operating characteristic (JAFROC) as described by 
Chakraborty (18). The performance of triple arterial phase MIP 
and single arterial phase CT was estimated by using the area un-
der the JAFROC curve, including 95% confidence intervals.
scans) and follow-up images according 
to American Association for the Study 
of Liver Diseases/European Association 
for the Study of the Liver criteria (4,5) 
in 30 of 38 participants (79%) and/or 
histopathology reports in 11 (29%). The 
mean total follow-up time was 507 days 
(range, 74–897 days).
Readers 1 and 2 also assessed subjec-
tive overall image quality, arterial vessel 
depiction, and lesion depiction quality 
by using a four-point Likert scale, where 
1 = poor, 2 = moderate, 3 = good, and 4 
= excellent. In addition, they graded the 
presence and severity of motion artifacts 
as follows: 1 = nondiagnostic, severe arti-
facts; 2 = partly diagnostic, moderate ar-
tifacts; 3 = diagnostic, minimal artifacts; 
and 4 = diagnostic, no artifacts.
Objective image quality analysis.—
Reader 3 furthermore analyzed quanti-
tative image quality by placing circular 
regions of interest (ROIs). To evaluate 
lesion-to-liver contrast, lesion-to-liver 
contrast ratio, and contrast-to-noise 
ratio, one ROI was placed to delineate 
the hypervascular part of the lesion and 
two ROIs were placed in the liver paren-
chyma in close proximity to the lesion, 
avoiding vessels and other possible inho-
mogeneities (Fig 2).
Liver-to-lesion contrast was calcu-
lated by subtracting the mean CT num-
ber in the lesion from the mean CT 
number in the liver. The lesion-to-liver 
contrast ratio was calculated by dividing 
the liver-to-lesion contrast by the CT 
number in the liver. The contrast-to-
noise ratio was calculated by dividing 
the liver-to-lesion contrast by the mean 
standard deviation of the attenuation 
measurement in the liver.
For the evaluation of image noise, 
two additional ROIs were placed in 
the air surrounding the study subject. 
Image noise was calculated as follows: 
(mean standard deviationliver + mean 
standard deviationair)/2.
Statistical Methods
Quantitative data were descriptively reviewed and tested for 
normality by using the Shapiro-Wilk test. Normally distributed 
variables were compared by using the paired Student t test. Non-
parametric data were compared by using the Wilcoxon signed 
rank test. Calculated sensitivities for each reader are presented 
with the Wilson confidence interval. True- and false-positive rat-
Figure 1: (a) Diagram illustrates variation of peak enhancement times in 27 hepatocellular car-
cinomas (HCCs) from 15 participants in group A. Enhancement curves for the HCCs with the mini-
mum (8 seconds), mean (14 seconds), and maximum (24 seconds) times to peak enhancement are 
shown. Peak enhancement times were corrected for cardiac output variations by subtracting the time 
until 160 HU was reached in abdominal aorta. Red curve = aorta, green curves = HCC lesions. 
Black dashed vertical line indicates time point when 160 HU was reached in abdominal aorta. Blue 
dashed vertical lines indicate peak enhancement in each of the three shown HCC enhancement 
curves. (b) CT images in 58-year-old man with biopsy-proven HCC in liver segment III. CT images 
from these three specific arterial time points were isolated from a complete perfusion CT data set 
and fused into one time-resolved triple arterial phase maximum intensity projection (MIP ) image.
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Statistical Package for the Social Sciences Statistics, release 
24.0; SPSS, Chicago, Ill). P , .05 was considered indicative of 
a statistically significant difference.
Results
Dose-equivalent Triple Arterial Phase MIP Protocol
Data postprocessing consisting of noise reduction, motion cor-
rection, and image fusion from three arterial time points was 
feasible in all 38 participants in group B.
Radiation doses are listed in Table 2. There was no sig-
nificant difference between the mean radiation dose of triple 
arterial phase MIPs (mean dose-length product, 223.3 mGy 
× cm) derived from perfusion CT and that of single arterial 
phases (mean dose-length product, 227.52 mGy × cm) from 
standard CT (P = .73).
Arterial Peak Enhancement of HCC
The mean corrected time to peak enhancement of the 27 HCCs 
in group A was 13.4 seconds 6 3.6. The time to peak enhance-
ment was 8.1 seconds in the fastest-enhancing HCC and 23.7 
seconds in the slowest-enhancing HCC. Thus, the time to peak 
enhancement of all 27 HCCs had a range of 15.6 seconds even 
though the measurements were corrected for cardiac output 
variations by simulating the bolus-tracking technique (Fig 1).
Diagnostic Performance in HCC Detection
Of the 38 study participants in group B, 27 subjects (71%) 
had HCC, one subject (3%) had both HCC and histopatho-
logically proven intrahepatic cholangiocarcinoma, one subject 
(3%) had intrahepatic cholangiocarcinoma, seven subjects 
(18%) had only lesions that did not fulfill diagnostic criteria 
for HCC, and two subjects (5%) had no visible lesions at all.
Reader 3 identified 136 lesions in total. Readers 1 and 2 
detected 133 of the 136 lesions (98%). Of those 133 lesions, 
65 (48.9%) fulfilled diagnostic criteria for HCC.
The average HCC size at triple arterial phase MIP was 24.7 
mm (range, 10–95 mm) for reader 1 and 29.4 mm (range, 
10–120 mm) for reader 2. At single arterial phase CT, the av-
erage HCC size was 25.0 mm (range, 10–115 mm) for reader 
1 and 30.0 mm (range, 10–150 mm) for reader 2. There was 
no difference in measured size between triple arterial phase 
MIP and single arterial phase CT for either reader (P = .78 
and P = .50, respectively).
HCC detection rates are shown in Table 3. The detection 
rate of the 65 HCC lesions was 82% for reader 1 and 83% 
for reader 2 at triple arterial phase MIP and 80% for reader 
1 and 77% for reader 2 at single arterial phase CT (P = .4). 
There were no significant differences in the readers’ overall 
performance between triple arterial phase MIP and single ar-
terial phase CT (area under the curve: 0.73 [95% confidence 
interval: 0.61, 0.85] vs 0.60 [95% confidence interval: 0.43, 
0.77], respectively; P = .15). Of the HCC lesions that were 
missed on single arterial phase images, seven and nine were 
detected by reader 1 and reader 2, respectively, on triple arte-
rial phase MIP images (Fig 3). Of the HCC lesions that were 
missed on triple arterial phase MIP images, six and five were 
The reliability of qualitative image evaluation was as-
sessed by using the two-way random intraclass correlation 
coefficient of both readers, whereas the interobserver agree-
ment for HCC detection between reader 1 and reader 2 was 
assessed with Cohen k analysis. According to Landis and 
Koch (19), a Cohen k coefficient of less than 0 is indicative 
of no agreement, 0–0.20 slight agreement, 0.21–0.40 fair 
agreement, 0.41–0.60 moderate agreement, 0.61–0.80 sub-
stantial agreement, and 0.81–1 almost-perfect agreement.
All statistical analyses other than JAFROC analysis were 
performed by using commercially available software (IBM 
Figure 2: Example of region of interest (ROI) place-
ment for objective image quality analysis. CT image was 
obtained in 56-year-old woman with arterial hyperen-
hancing lesion in liver segment V. One ROI delineates 
lesion, two ROIs are in liver parenchyma surrounding the 
lesion, and two ROIs are in air. All ROIs are 0.40 cm2. 
Numbers indicate attenuation inside ROIs, in Hounsfield 
units. Numbers in parentheses are standard deviation of 
each measurement, which was used for noise assessment.
Table 3: HCC Detection Rates
Reader and  
Protocol
No. of  
True-Positive  
Findings
No. of  
False-Positive  
Findings Sensitivity (%)
Reader 1
 Triple arterial  
  phase protocol
53 30 82 (70, 89)
 Single arterial  
  phase protocol
52 39 80 (69, 88)
Reader 2
 Triple arterial  
  phase protocol
54 20 83 (72, 90)
 Single arterial  
  phase protocol
50 30 77 (65, 85)
Note.—There were 65 hepatocellular carcinomas (HCCs). 
Numbers in parentheses are 95% confidence intervals. For overall 
performance, the area under the curve for the triple arterial phase 
protocol was 0.73 (95% confidence interval: 0.61, 0.85). The 
area under the curve for the single arterial phase protocol was 
0.60 (95% confidence interval: 0.43, 0.77).
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reader 2: P = .071). The single arterial phase protocol showed 
significantly better results in lesion depiction quality for both 
readers compared with the triple arterial phase MIP protocol (P 
, .001 for readers 1 and 2). The qualitative image evaluation 
showed high reliability for both triple arterial phase MIP (intra-
class correlation coefficient, 0.726; P , .001) and single arterial 
phase CT (intraclass correlation coefficient, 0.735; P , .001).
Discussion
Our study demonstrated that triple arterial phase MIP im-
aging with a radiation dose equivalent to that of standard 
single arterial phase CT is feasible. It provides an equiva-
lent-to-superior image quality and HCC detection rate de-
spite a lower contrast material dose than at standard late 
arterial phase CT.
Variations in HCC enhancement curves due to cardiac 
output differences were minimized by correcting peak en-
hancement times with use of simulated bolus tracking in the 
detected by reader 1 and reader 2, respectively, on single arte-
rial phase images (Fig 4). Only six of the 65 HCCs (9.2%) 
were missed by both readers with both protocols. Interob-
server agreement was fair for both the triple arterial phase 
MIP image set (k = 0.366, P , .001) and the single arterial 
phase image set (k = 0.399, P , .001).
Objective and Subjective Image Quality Analysis
Results of image quality assessment are summarized in Table 4. 
Image noise was significantly lower (P , .001) and contrast-
to-noise ratio significantly higher (P = .032) for triple arterial 
phase MIP image sets than for single arterial phase image sets. 
Lesion-to-liver contrast, however, was significantly higher for 
single arterial phase image sets (P = .014). The lesion-to-liver 
contrast ratio showed no significant difference between the two 
protocols (P = .312).
There was no significant difference between the protocols at 
subjective overall image quality assessment (reader 1: P = .433; 
Figure 4: CT images in 64-year-old man with a histologically proven hepatocellular carcinoma (HCC) (arrow) in liver 
segment VII. HCC arterial hyperenhancement was not depicted on (a) triple arterial phase maximum intensity projection 
image but was seen on (b) standard single arterial phase image.
Figure 3: CT images in 58-year-old man with histopathologically proven hepatocellular carcinoma (HCC) (arrow) in 
liver segment III (same subject as in Fig 1b). HCC was detected on (a) triple arterial phase maximum intensity projection 
image and missed on (b) standard single arterial phase image.
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two-to-threefold higher amounts of contrast material. This 
resulted in stronger absolute iodine enhancement in both 
liver parenchyma and HCC lesions. However, although the 
liver-to-lesion contrast was higher with standard CT, the 
liver-to-lesion contrast ratio was equal for both protocols, 
suggesting that the relative enhancement difference in HCC 
versus liver parenchyma was not affected by the lower amount 
of contrast material used in the triple arterial phase MIP pro-
tocol. The higher amount of contrast material might also ex-
plain why subjective lesion depiction quality was superior for 
single arterial phase CT.
To our knowledge, this is the first study to evaluate the 
diagnostic performance of a triple arterial phase MIP proto-
col in the detection of HCC at the same radiation dose as a 
standard late arterial phase protocol. Our results showed that 
there is no overall difference in the diagnostic performance of 
both protocols, although the triple arterial phase MIP pro-
tocol was performed with significantly less contrast material 
(50 mL vs 120 mL). This may indicate that the triple arterial 
phase MIP protocol presented could be used in patients with 
renal impairment to reduce contrast material doses without 
losing diagnostic accuracy. We also speculate that the triple 
arterial phase MIP protocol with a standard iodine dose 
could result in higher detection rates of HCC compared with 
a conventional single arterial phase protocol. This concept is 
supported by our observation that several HCC lesions were 
exclusively detected on either triple arterial phase MIP images 
or standard single arterial phase images with a high contrast 
material dose. This indicates that both protocols have their 
benefits: better contrast material timing with triple arterial 
phase MIP and higher contrast material dose for the standard 
late arterial phase CT.
Our study had several limitations. First, the triple arte-
rial phase MIP protocol was derived from a time-resolved 
perfusion CT data set consisting of 28 time points. This 
study showed that a dose-equivalent triple arterial phase 
MIP protocol is feasible, with similar to better image qual-
ity and HCC detection rates compared with standard late 
arterial phase imaging. However, the implementation of 
triple arterial phase MIP into a standard multiphasic CT 
liver protocol using higher contrast material doses must be 
further evaluated. Second, histopathologic proof of HCC 
was available in only 21 of the 65 HCC lesions in group B 
(32%); in 44 of the 65 lesions (68%), imaging follow-up 
served as the reference standard. Third, perfusion CT was, 
for logistic reasons, performed approximately 10 minutes 
before clinical multiphasic CT. There is a risk that residual 
contrast material from perfusion CT could have influenced 
the results of the subsequent standard single arterial phase 
CT examination. Moreover, the study focused on detecting 
arterialized lesions larger than 9 mm in chronic liver disease, 
which also includes entities other than HCC. However, the 
aim of the study was to compare the value and detection 
rates of the proposed triple arterial phase MIP protocol ver-
sus the standard late arterial phase protocol. Inclusion of the 
portal venous or late venous phases to the read-out would 
have influenced detection rates.
abdominal aorta. However, there was still a great variation in 
the arterial peak enhancement time of HCC, with a range of 
15.6 seconds. This great variation might be due to a substan-
tial change in arterial supply during carcinogenesis of HCC 
(20) and might reflect different stages of dedifferentiation. This 
finding is consistent with that in a previous study by Gordic 
et al (21) underlining the difficulty of depicting an optimally 
timed late arterial phase and indicating the possible benefit of 
capturing multiple arterial time points.
Previously, multiple arterial phase CT suffered from high 
radiation doses, but this limitation can now be overcome with 
use of noise reduction and image fusion algorithms, which 
markedly improve the image quality of low-dose image sets 
(15,22). Whereas motion correction was of minor concern in 
our study because the arterial phase was acquired during breath 
hold, the software-integrated multiband frequency–dependent 
filtering technique was shown to substantially reduce noise and 
improve image quality of the raw data (15). Interestingly, the 
objective image quality of reconstructed time-resolved MIPs 
derived from three low-dose scans was better than that of dose-
equivalent standard CT images, which is in line with findings 
in a previous study by Wang et al (22).
Both protocols were performed with a tube voltage 
of 80 kV, but the standard protocol was performed with 
Table 4: Image Quality
Image Quality
Triple Arterial  
Phase MIP
Single Arterial  
Phase CT P Value
Objective image quality*
 Image noise (HU) 7.0 6 2.7 15.0 6 3.0 ,.001
 LLR 0.70 6 0.59 0.75 6 0.51 .312
 LLC 51 6 33 96 6 54 .014
 Lesion CNR 7.3 6 6.1 4.2 6 2.8 .032
Subjective image quality†
 Reader 1
  Arterial vessel  
   depiction
4 (3–4) 4 (2–4) .157
  Motion artifacts 4 (4–4) 4 (3–4) .157
  Overall image  
   quality
4 (1–4) 3 (2–4) .433
  Lesion depiction  
   quality
2 (1–4) 3 (1–4) ,.001
 Reader 2
  Arterial vessel  
   depiction
4 (3–4) 4 (2–4) .046
  Motion artifacts 4 (2–4) 4 (3–4) .013
  Overall image  
   quality
4 (2–4) 4 (2–4) .071
  Lesion depiction  
   quality
3 (1–4) 4 (1–4) ,.001
Note.—CNR = contrast-to-noise ratio, HU = Hounsfield units, 
LLC = lesion-to-liver contrast, LLR = lesion-to-liver contrast 
ratio, MIP = maximum intensity projection.
* Data are means 6 standard deviations.
† Data are median scores, with range in parentheses.
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In conclusion, the triple arterial phase MIP protocol is feasi-
ble at the same radiation dose as the standard late arterial phase 
protocol with use of a new postprocessing technique. Triple ar-
terial phase MIP provides equivalent-to-superior image quality 
and an equivalent HCC detection rate despite using less than 
half the contrast material dose employed at standard single ar-
terial phase CT.
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